INS and colorectal carcinoma: The insulin-sensitizing anti-diabetic activities of MEDICA were indeed reproduced here in the CRC diabetic animal model, in terms of decrease in body weight gain, and fasting blood glucose, insulin and leptin, while maintaining food consumption.